Casdin Capital, LLC

Average Profitability
24.74%
Insider Buys Quantity
6
Insider Buys Sum
$33.24M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Casdin Capital, LLC

According to the SEC Form 4 filings, Casdin Capital, LLC, being in a position of

  1. director at 2seventy bio, Inc.,
    оver the last 12 months, has bought 817377 shares for $4.1M, and sold 0 shares,
    over all time since 2024-03-21, has bought 817377 shares for $4.1M, and sold 0 shares.

The largest purchase of all time was on 2020-06-16 and amounted to 1300000 shares of Generation Bio Co. for $24.7M.

Biography of Casdin Capital, LLC

No biography is available at this moment.

2024-03-26Purchase2seventy bio, Inc.
TSVT
director
40,000
0.0812%
$5.10$203,992-7.46%
2024-03-25Purchase2seventy bio, Inc.
TSVT
director
330,000
0.6747%
$5.07$1.67M-6.33%
2024-03-22Purchase2seventy bio, Inc.
TSVT
director
147,377
0.2903%
$5.12$754,069-10.43%
2024-03-21Purchase2seventy bio, Inc.
TSVT
director
300,000
0.5822%
$4.90$1.47M-8.18%
2020-06-16PurchaseGeneration Bio Co.
GBIO
10 percent owner
1.3M
10.4125%
$19.00$24.7M+47.36%
2019-07-22PurchaseFulcrum Therapeutics, Inc.
FULC
10 percent owner
280,000
1.9482%
$15.84$4.43M+2.11%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.